국제약품(주) · KOSPI: 002720 · Pharmaceuticals and medicinal chemicals
| KRW | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | ₩135.4B | ₩156.5B | ₩175.5B |
| Operating income | −₩2.0B | ₩6.7B | ₩6.2B |
| Net income | −₩8.4B | ₩5.2B | ₩5.7B |
| Total assets | ₩163.3B | ₩165.5B | ₩182.3B |
| Total liabilities | ₩78.3B | ₩76.0B | ₩84.6B |
| Total equity | ₩84.9B | ₩89.5B | ₩97.7B |
| Share capital | ₩21.2B | ₩21.2B | ₩21.2B |
Consolidated statements · FY2025 operating margin 3.5% · liabilities to equity 87% · Annual report FY2025 (Korean original)
| Period | Auditor | Opinion |
|---|---|---|
| Term 68 (current) | 대성회계법인 | Unqualified |
| Term 67 (prior) | 대성삼경회계법인 | Unqualified |
| Term 66 (two years prior) | 신한회계법인 | Unqualified |
No change history reported in the latest annual report.
| Date | Filing | Original |
|---|---|---|
| 2026-09-04 | Officer / major shareholder trading plan report | DART |
| 2026-09-04 | Officer / major shareholder trading plan report | DART |
| 2026-08-24 | New facility investment | DART |
| 2026-08-14 | Half-year report (2026.06) | DART |
| 2026-08-11 | Large shareholding (5%+) report | DART |
| 2026-07-10 | Officer / major shareholder ownership report | DART |
| 2026-06-05 | Officer / major shareholder ownership report | DART |
| 2026-06-01 | Corporate governance report | DART |
| 2026-05-29 | Officer / major shareholder ownership report | DART |
| 2026-05-29 | Large shareholding (5%+) report | DART |
| 2026-05-27 | Officer / major shareholder ownership report | DART |
| 2026-05-20 | Amended: Decision to guarantee debt of another party | DART |
| 2026-05-15 | Quarterly report (2026.03) | DART |
| 2026-03-26 | Independent director appointment / dismissal / resignation | DART |
| 2026-03-26 | Annual general meeting results | DART |
| 2026-03-18 | Annual report (2025.12) | DART |
| 2026-03-17 | Audit report submitted | DART |
| 2026-03-04 | Proxy solicitation reference document | DART |
| 2026-02-25 | Resolution to convene shareholders meeting | DART |
| 2026-02-25 | Record date for cash / in-kind dividend | DART |
Showing the 20 most recent of 29 filings. The full brief lists all of them.
For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).
Data generated 2026-09-16 from OpenDART.
This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.